Revvity at AMP 2026

Nov 10–14, 2026 Seattle, WA ~2k attendees Website

Revvity brings 1 presentation to AMP 2026 in Seattle, and exhibits at Booth 916. Its session covers nucleic acid extraction strategies for molecular oncology, across liquid biopsy and FFPE samples. The company offers health science technologies spanning multiomics, biomarker identification, imaging, screening, detection and informatics.

OrganizationAMP 2026 Attendance
Revvity
Waltham, MA
Suppliers
Health science technologies and services spanning translational multiomics, biomarker identification, imaging, screening, detection, diagnosis and informatics.
Booth
Exhibiting at Booth 916
Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm
Workshop
Wed, Nov 11
1:00pm–1:50pm
Strategies for Optimizing Nucleic Acid Extraction in Molecular Oncology Workflows: Liquid Biopsy, FFPE, and Beyond
Magnetic bead extraction tuned for high-throughput oncology workflows, covering FFPE tissue and cell-free DNA from plasma.

Explore the full AMP 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Seattle. Leave your work email and we’ll be in touch.

Privacy

Download the full AMP 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Revvity

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with the Association for Molecular Pathology. Organization details are derived from AMP’s published lists. Submit a correction